GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (FRA:YB3) » Definitions » Deferred Tax

Shin Nippon Biomedical Laboratories (FRA:YB3) Deferred Tax : €0.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Shin Nippon Biomedical Laboratories's change in deferred tax for the three months ended in Dec. 2023 was €0.0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2023 was €0.0 Mil.

Shin Nippon Biomedical Laboratories Deferred Tax Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shin Nippon Biomedical Laboratories Deferred Tax Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Shin Nippon Biomedical Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Shin Nippon Biomedical Laboratories Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shin Nippon Biomedical Laboratories Deferred Tax Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Shin Nippon Biomedical Laboratories (FRA:YB3) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (FRA:YB3) » Definitions » Deferred Tax
Comparable Companies
TSE:2309 TSE:4694 TSE:4671 TSE:7707 TSE:3386 TSE:2397 TSE:6090 TSE:4544 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX
Traded in Other Exchanges
2395:Japan
Address
8-1 Akashi-cho, Tokyo, JPN
Website
http://www.snbl.co.jp
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories (FRA:YB3) Headlines

No Headlines